MedPath

This is an interventional study to assess and compare Semaphorin 4D, Peptidylarginine Deiminase 2 and Matrix Metalloproteinase-8 in Gingival crevicular fluid levels before and after Non-surgical periodontal therapy in periodontally healthy, Severe periodontitis Smoker and non-smoker patients.

Not Applicable
Conditions
Health Condition 1: K053- Chronic periodontitis
Registration Number
CTRI/2020/03/024346
Lead Sponsor
Dr Aishwarya Ikhar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Group I: Periodontally healthy patients.

Group II: Non-Smoker patients with untreated stage III periodontitis, with PPD more than equal to 5 mm and CAL more than equal to 4mm, BOP at >50% of sites (full mouth) and radiographic evidence of interproximal bone loss.

Group III: Smoker patients with untreated stage III periodontitis, with PPD more than equal to 5 mm and CAL more than equal to 4mm, BOP at >50% of sites (full mouth) and radiographic evidence of interproximal bone loss.

Exclusion Criteria

1.Patients who had received periodontal treatment within the last 6 months.

2.Patients with any systemic diseases.

3.Patients who had or are on immunosuppressive chemotherapy.

4.Use of antibiotics within the last 6 months and anti-inflammatory drugs within the last 3 months.

5.Pregnant and lactating females.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath